Chairman and CEO of C.R. Bard Inc. (bcr) Timothy M Ring sells 14,147 shares of bcr on 01/04/2010 at an average price of $78.62 a share.
C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas. C.r. Bard Inc. has a market cap of $7.6 billion; its shares were traded at around $78.68 with a P/E ratio of 16.1 and P/S ratio of 3.1. The dividend yield of C.r. Bard Inc. stocks is 0.9%. C.r. Bard Inc. had an annual average earning growth of 14.5% over the past 10 years. GuruFocus rated C.r. Bard Inc. the business predictability rank of 3-star.
BCR is in the portfolios of Chris Shumway of Shumway Capital Partners LLC, Jeremy Grantham of GMO LLC, Chuck Royce of ROYCE & ASSOCIATES.
C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas. C.r. Bard Inc. has a market cap of $7.6 billion; its shares were traded at around $78.68 with a P/E ratio of 16.1 and P/S ratio of 3.1. The dividend yield of C.r. Bard Inc. stocks is 0.9%. C.r. Bard Inc. had an annual average earning growth of 14.5% over the past 10 years. GuruFocus rated C.r. Bard Inc. the business predictability rank of 3-star.
BCR is in the portfolios of Chris Shumway of Shumway Capital Partners LLC, Jeremy Grantham of GMO LLC, Chuck Royce of ROYCE & ASSOCIATES.
CEO Recent Trades:
- Sell:: Chairman and CEO Timothy M Ring sold 14,147 shares of BCR stock on 12/01/2009 at the average price of 82.59, the price of the stock has decreased by 4.73% since.
- Sell:: Chairman and CEO Timothy M Ring sold 14,147 shares of BCR stock on 11/02/2009 at the average price of 75.25, the price of the stock has increased by 4.56% since.
- Sell:: Chairman and CEO Timothy M Ring sold 14,147 shares of BCR stock on 10/01/2009 at the average price of 78.12, the price of the stock has increased by 0.72% since.
- Sell:: Chairman and CEO Timothy M Ring sold 14,147 shares of BCR stock on 09/01/2009 at the average price of 80.55, the price of the stock has decreased by 2.32% since.
- Sell:: Chairman and CEO Timothy M Ring sold 14,147 shares of BCR stock on 08/03/2009 at the average price of 74, the price of the stock has increased by 6.32% since.
Directors and Officers Recent Trades:
- Sell:: Group Vice President Sharon M Alterio sold 2,784 shares of BCR stock on 11/09/2009 at the average price of 79.36, the price of the stock has decreased by 0.86% since.
- Sell:: Director Gail K Naughton sold 418 shares of BCR stock on 10/26/2009 at the average price of 75.62, the price of the stock has increased by 4.05% since.
- Sell:: President and COO John H Weiland sold 36,590 shares of BCR stock on 09/01/2009 at the average price of 80.51, the price of the stock has decreased by 2.27% since.
- Sell:: Group Vice President Jim C Beasley sold 500 shares of BCR stock on 08/31/2009 at the average price of 80.54, the price of the stock has decreased by 2.31% since.
- Sell:: Group Vice President Brian P Kelly sold 10,501 shares of BCR stock on 08/27/2009 at the average price of 78.45, the price of the stock has increased by 0.29% since.
